Response to interferon beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria

被引：0
|
作者：
Portaccio, E [1 ]
Zipoli, V [1 ]
Siracusa, G [1 ]
Sorbi, S [1 ]
Amato, MP [1 ]
机构：
[1] Univ Florence, Florence, Italy
来源：
JOURNAL OF NEUROLOGY | 2005年 / 252卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [21] Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
    Cocco, Eleonora
    Marrosu, Maria Giovanna
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 759 - 766
  • [22] The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis
    Madsen, Claus
    [J]. BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [23] Beta-interferons in the therapy of relapsing-remitting multiple sclerosis
    Klimová, E
    Szilasiová, J
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2003, 66 (05) : 343 - +
  • [24] Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients
    Romeo, M.
    Martinelli-Boneschi, F.
    Rodegher, M.
    Esposito, F.
    Martinelli, V.
    Comi, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (07) : 1060 - 1067
  • [25] Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
    Río, J
    Nos, C
    Tintoré, M
    Téllez, N
    Galán, I
    Pelayo, R
    Comabella, M
    Montalban, X
    [J]. ANNALS OF NEUROLOGY, 2006, 59 (02) : 344 - 352
  • [26] Recombinant human interferon beta in relapsing-remitting multiple sclerosis: a review of the major clinical trials
    Chofflon, M
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 (04) : 369 - 380
  • [27] Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
    Sorensen, PS
    Ross, C
    Clemmesen, KM
    Bendtzen, K
    Frederiksen, JL
    Jensen, K
    Kristensen, O
    Petersen, T
    Rasmussen, S
    Ravnborg, M
    Stenager, E
    Koch-Henriksen, N
    [J]. LANCET, 2003, 362 (9391): : 1184 - 1191
  • [28] Glatiramer acetate in interferon beta non respondent relapsing-remitting multiple sclerosis
    Oreja-Guevara, C.
    Bermejo, P. E.
    Miralles, A.
    Gabaldon, L.
    Aguilar, M. J.
    Diez-Tejedor, E.
    [J]. NEUROLOGIA, 2009, 24 (07): : 435 - 438
  • [29] The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
    Livia Lovato Pires de Lemos
    Augusto Afonso Guerra Júnior
    Marisa Santos
    Carlos Magliano
    Isabela Diniz
    Kathiaja Souza
    Ramon Gonçalves Pereira
    Juliana Alvares
    Brian Godman
    Marion Bennie
    Ivan Ricardo Zimmermann
    Vânia Crisitna Canuto dos Santos
    Clarice Alegre Pretramale
    Francisco de Assis Acurcio
    [J]. PharmacoEconomics, 2018, 36 : 161 - 173
  • [30] Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis
    Zhang, Jian
    Shi, Shengliang
    Zhang, Yueling
    Luo, Jiefeng
    Xiao, Yousheng
    Meng, Lian
    Yang, Xiaobo
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
12345